Komori
Takara Bio (4974) · RiskMaterialisedLatest Earnings (2026-05-13): "Cited as achieved"

Impairment Risks Relating to Production Facilities, Acquired Businesses and Goodwill

First written in FY2023. 2 of 6 entries say "Restated". Latest entry: 2026-05-13.

6entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023 – FY2024-Q3RestatedFY2025-H1MaterialisedFY2026-H12023: 120232024: 320242025: 120252026: 12026
Same theme, other companies

The whole theme swung hardest in 2020: 51 of 96 companies on the "Worse" side.

0 other companies' latest entry also says "Cited as achieved".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 189 companies compared. The sentences above are computed from all 189.Comparing 200 of the theme's 420 threads.
Full recordFilings, disclosures and news, newest first
  1. 2026-05-13Cited as achievedEarnings

    「税金等調整前当期純損失は、未稼働の受託製造にかかる設備等の減損損失3,876百万円を計上したこと等により、9,200百万円(前期は税金等調整前当期純利益1,997百万円)となりました。」

    未稼働の受託製造設備等に関する減損リスクの実績化を、通期決算の減損損失3,876百万円として引用している。
  2. FY2026-H1MaterialisedAnnual report

    「増設した一部の設備を回収可能価額まで減額し、当該減少額を減損損失として特別損失に計上しております。」

    未稼働の受託製造設備について減損損失3,870百万円を計上した。正味売却価額は売却可能性が見込まれず、使用価値も将来キャッシュ・フローが見込まれないため、回収可能価額を零として評価している。
  3. FY2025-H1RestatedAnnual report

    「During the current interim consolidated accounting period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    生産設備・買収事業・のれん等の減損リスクについて、新規発生または重要な変更はないとしている。
  4. FY2024MitigatedAnnual report

    「このようなリスクを踏まえ、当社グループでは買収後のシナジー実現に向けた買収事業のフォローアップや、マクロ経済環境の定期的なモニタリングを行っております。」

    生産設備の遊休化・稼働率低下、買収事業の計画未達による減損リスクに対し、買収後フォローアップとマクロ経済環境の定期的モニタリングを実施している。
  5. FY2024-Q3RestatedAnnual report

    「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    生産設備・買収事業・のれん等の減損リスクについて、新規発生または重要な変更はないとしている。なお、四半期連結損益計算書には減損損失75百万円が計上されているが、その発生原因は当該リスクとの関係を明示していない。
  6. FY2023First statedAnnual report

    「Idle production facilities or lower utilization rates resulting from rapid changes in the business environment, or acquired businesses performing below their initial plans, may result in impairment losses and affect the Group’s financial results.」

    First separately disclosed impairment risks for property, plant and equipment, intangible assets and goodwill arising from idle or underutilized production facilities and acquired businesses failing to meet plans.
Moved together

"CDMO Business Centered on the Gene and Cell Processing Center" moved the same way as this thread, in the same document, in 2 of its 6 moves.

2★1
  1. ★This thread
  2. 1CDMO Business Centered on the Gene and Cell Processing Center2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Takara Bio yet. It last moved in the Earnings of 2026-05-13: "Cited as achieved".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.